University Venture Fund II is first money in Navigen Pharmaceuticals seed round
SALT LAKE CITY—The Sorenson Impact Center’s University Venture Fund - Impact Investing (UVF II) closed its first investment in a seed round into Salt Lake City-based Navigen, Inc. UVF II’s investment was highly catalytic, unlocking over $1.5 million additional investment capital into the pharmaceutical company. Navigen, Inc. is an early-stage drug discovery and development company that has developed a D-peptide drug discovery platform to [...]
